Literature DB >> 21361931

Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008.

Shane Darke1, Johan Duflou, Michelle Torok.   

Abstract

All cases of fatal oxycodone toxicity presenting to the New South Wales Department of Forensic Medicine over the period January 1, 1999, to December 31, 2008, were retrieved. A total of 70 cases were identified. The mean age was 48.9 years, 58.6% were men, 21.4% were suicides, and in 30% oxycodone had not been prescribed to the decedent. Injecting drug users constituted 27.1% of cases, and oxycodone tablets were injected immediately prior to death by 21.4%. The mean blood oxycodone concentration was 0.40 mg/L (range 0.06-53.00 mg/L). In all cases, psychoactive substances other than oxycodone were also detected, most frequently hypnosedatives (68.6%), other opioids (54.3%), antidepressants (41.4%), and alcohol (32.9%). Preexisting systemic disease was common: cardiovascular (64.2%), pulmonary (49.3%), hepatic (66.7%), and renal (43.9%).
© 2011 American Academy of Forensic Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21361931     DOI: 10.1111/j.1556-4029.2011.01703.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  7 in total

Review 1.  Dependence and addiction during chronic opioid therapy.

Authors:  David N Juurlink; Irfan A Dhalla
Journal:  J Med Toxicol       Date:  2012-12

2.  What analgesics do older people use prior to initiating oxycodone for non-cancer pain? A retrospective database study.

Authors:  Svetla Gadzhanova; J Simon Bell; Elizabeth E Roughead
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

Review 3.  Pharmacokinetic Pharmacodynamic Modelling Contributions to Improve Paediatric Anaesthesia Practice.

Authors:  James D Morse; Luis Ignacio Cortinez; Brian J Anderson
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

4.  Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia.

Authors:  Andrea L Schaffer; Nicholas A Buckley; Louisa Degenhardt; Briony Larance; Rose Cairns; Timothy A Dobbins; Sallie-Anne Pearson
Journal:  CMAJ       Date:  2018-03-26       Impact factor: 8.262

5.  Criminality and suicide: a longitudinal Swedish cohort study.

Authors:  M Stenbacka; A Romelsjö; J Jokinen
Journal:  BMJ Open       Date:  2014-02-03       Impact factor: 2.692

6.  Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study.

Authors:  Yong Joo Lee; Sang-Yeon Suh; Junghan Song; Sanghee Shiny Lee; Ah-Ram Seo; Hong-Yup Ahn; Myung Ah Lee; Chul-Min Kim; Pål Klepstad
Journal:  BMC Palliat Care       Date:  2015-10-27       Impact factor: 3.234

7.  Prescribers' views and experiences of assessing the appropriateness of prescribed medications in a specialist addiction service.

Authors:  Adejoke Obirenjeyi Oluyase; Duncan Raistrick; Elizabeth Hughes; Charlie Lloyd
Journal:  Int J Clin Pharm       Date:  2017-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.